ACE and stroke disorder: Recent experimental and human data suggest that ACE-Is reduce proliferations of vascular smooth muscle, enhance endogenous fibrinolysis, inhibit plaque rupture and vascular occlusion.[17] If this is true, can ACE-Is be used effectively in acute ischemic stroke as agents to improve stroke outcome?